ReviewBritish journal of clinical pharmacology2026
Designing equitable and inclusive assessments in pharmacology: Insights from education practices in medical sciences.
Review in British journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Using assessment in pharmacology to drive learning in the right direction.British journal of clinical pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inclusive assessment is essential in higher education to ensure that all students, regardless of background, ability, or circumstance, have equitable opportunities to demonstrate their learning. In high-stakes disciplines such as pharmacology and other medical sciences, where assessment outcomes significantly influence academic progression and professional qualification, embedding inclusive practices is particularly important. Equity, diversity, and inclusion (EDI) have emerged as central principles in shaping contemporary educational approaches, especially in how we design and deliver assessments. Integrating EDI into pharmacology assessment is critical for creating learning environments that are fair, accessible and responsive to the needs of a diverse student body, including individuals from varied cultural and socio-economic backgrounds, those with disabilities and neurodivergent learners. This review examines the theoretical underpinnings and practical applications of inclusive assessment within pharmacology and related health science disciplines and integrates practical examples to highlight innovative strategies that promote equitable and pedagogically sound evaluation of student learning. In doing so, the paper also acknowledges the systemic and institutional challenges that may impede implementation and proposes evidence-informed, actionable recommendations to address these barriers. The overarching aim is to support educators in advancing inclusive assessment practices that not only foster academic success and fairness but also contribute to the development of a diverse, capable health-care workforce equipped to navigate the complex health challenges of the 21st century.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.